Pediatric patients with ALL experience, on average, about 15 different symptoms in their chemotherapy journey.

Repeat biopsies in patients with TNBC may detect changes in HER2 status and allow more patients to gain access to T-DXd, data suggest.

Adherence to American Cancer Society guidelines linked to lower mortality in nonsmoking survivors of obesity-related cancer.

Luveltamab tazevibulin demonstrated activity in an ongoing phase 2/3 trial of patients with FRα-positive, platinum-resistant ovarian cancer.